GUANABENZ - A CENTRALLY ACTING, NATRIURETIC ANTIHYPERTENSIVE DRUG

被引:20
作者
GEHR, M [1 ]
MACCARTHY, EP [1 ]
GOLDBERG, M [1 ]
机构
[1] UNIV CINCINNATI, COLL MED, DEPT INTERNAL MED, DIV NEPHROL, CINCINNATI, OH 45267 USA
关键词
D O I
10.1038/ki.1986.128
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Guanabenz is acutely natriuretic and diuretic in saline expanded animals. In man, guanabenz has not resulted in sodium retention as seen with other comparable antihypertensives. To directly define the action of guanabenz on sodium and water excretion in man, we performed clearance studies during water diuresis on eight hypertensive subjects under metabolic balance conditions. Each subject underwent three studies: 1) baseline study: no drug, a water diuresis study; this was followed by a saline load (=2% BW); 2) acute study (24 hr after baseline): 16 mg guanabenz PO; and 3) chronic study: after one week of guanabenz 8 mg PO BID. In the acute guanabenz studies there were: 1) no changes in GFR or ERPF; 2) an increase in both sodium excretion and fractional sodium excretion; 3) a rise in free H2O clearance (CH2O) and (CH2O/GFR) .times. 100%. These findings were not sustained in the chronic guanabenz studies. We conclude that in man (preconditioned with prior saline loading) guanabenz is acutely natriuretic and water diuretic. These effects are due to decreased tubular sodium and water reabsorption, probably related to inhibition of alpha adrenergic activity. The data are consistent with selectively reduced renal sympathetic activity affecting sodium transport and provide a basis for the absence of edema and sodium retention associated with guanabenz therapy.
引用
收藏
页码:1203 / 1208
页数:6
相关论文
共 24 条
[1]  
BARR JG, 1979, J PHARMACOL EXP THER, V209, P389
[2]   EFFECTS OF GUANABENZ THERAPY ON RENAL-FUNCTION AND BODY-FLUID COMPOSITION [J].
BAUER, JH .
ARCHIVES OF INTERNAL MEDICINE, 1983, 143 (06) :1163-1167
[3]  
BAYLISS RIS, 1962, LANCET, V2, P763
[4]  
BOJESEN E, 1952, ACTA MED SCAND, V142, P226
[5]   RENAL EFFECTS OF GUANABENZ - NEW ANTIHYPERTENSIVE [J].
BOSANAC, P ;
DUBB, J ;
WALKER, B ;
GOLDBERG, M ;
AGUS, ZS .
JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 16 (11-1) :631-636
[6]   NEUROGENIC REGULATION OF RENAL TUBULAR SODIUM-REABSORPTION [J].
DIBONA, GF .
AMERICAN JOURNAL OF PHYSIOLOGY, 1977, 233 (02) :F73-F81
[7]  
DIBONA GF, 1982, REV PHYSL BIOCH PHAR, V94, P107
[8]   A COMPARISON OF PRE-JUNCTIONAL AND POST-JUNCTIONAL POTENCIES OF SEVERAL ALPHA-ADRENOCEPTOR AGONISTS IN THE CARDIOVASCULAR-SYSTEM AND ANOCOCCYGEUS MUSCLE OF THE RAT - EVIDENCE FOR 2 TYPES OF POST-JUNCTIONAL ALPHA-ADRENOCEPTOR [J].
DOCHERTY, JR ;
MCGRATH, JC .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1980, 312 (02) :107-116
[9]  
GOLUB MS, 1982, CLIN PHARMACOL THER, V2, P230
[10]   APPLICATION OF A RADIOIMMUNOASSAY FOR ANGIOTENSIN I TO PHYSIOLOGIC MEASUREMENTS OF PLASMA RENIN ACTIVITY IN NORMAL HUMAN SUBJECTS [J].
HABER, E ;
KOERNER, T ;
PAGE, LB ;
KLIMAN, B ;
PURNODE, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1969, 29 (10) :1349-+